Live feed
Filing
SC 13G
SC 13G0001104659-20-030172·Aclaris Therapeutics, Inc.
Schedule 13G ownership disclosure
Aclaris Therapeutics Inc
Security class unavailable · CUSIP: 00461U105
Event date: 2020-02-26
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,161,333
- Percent of class
- 5.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-20-030172
- Form type
- SC 13G
- Filer
- Aclaris Therapeutics, Inc.
- CIK
- CIK 1557746
- Filed
- Mar 06, 2020
- Reporting period
- Feb 26, 2020
- Description
- Schedule 13G beneficial ownership